Integral Health Asset Management, LLC Akebia Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

  • $850 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$2.39 - $13.08 $597,500 - $3.27 Million
-250,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$6.67 - $13.58 $333,500 - $679,000
50,000 Added 25.0%
250,000 $3.4 Million
Q1 2020

May 15, 2020
BUY
$4.1 - $10.24 $819,999 - $2.05 Million
200,000 New
200,000 $1.52 Million

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $324M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email